[1]Misu, T., Fujihara, K., Nakashima, I., Sato, S., & Itoyama, Y. (2005). Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optic-a. Neurology, 65(9), 1479.
[2]Takahashi, T., Miyazawa, I., Misu, T., Takano, R., Nakashima, I., Fujihara, K.,... Itoyama, Y. (2008). Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin–4 antibody: a herald of acute exacerbations. Journal of Neurology, Neurosurgery & Psychiatry, 79(9), 1075.
[3] Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M. I.,... Chitnis, T. (2015). Demographic and clinical features of neuromyelitis optica: A review. Multiple Sclerosis Journal, 21(7), 845–853. doi:10.1177/1352458515572406.
[4]Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007). The spectrum of neuromyelitis optica. The Lancet Neurology, 6(9), 805–815. doi:10.1016/S1474–4422(07)70216–8.
[5]Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T.,... Weinshenker, B. G. (2015). International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology, 85(2), 177–189. doi:10.1212/WNL.0000000000001729.
[6]Piga, M., Chessa, E., Peltz, M. T., Floris, A., Mathieu, A., & Cauli, A. (2017). Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis. Autoimmunity Reviews, 16(3), 244–252. doi:https://doi.org/10.1016/j.autrev.2017.01.011.
[7]Feng, X., Reder, N. P., Yanamandala, M., Hill, A., Franek, B. S., Niewold, T. B.,... Javed, A. (2012). Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis. Journal of the Neurological Sciences, 313(1), 48–53. doi:10.1016/j.jns.2011.09.032.
[8] Sá, M. J. (2009). Acute transverse myelitis: A practical reappraisal. Autoimmunity Reviews, 9(2), 128–131. doi:https://doi.org/10.1016/j.autrev.2009.04.005.
[9] Birnbaum, J., & Kerr, D. (2008). Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nature Clinical Practice Rheumatology, 4, 381. doi:10.1038/ncprheum0818.
[10]Joseph, A., Brasington, R., Kahl, L., Ranganathan, P., Cheng, T. P., & Atkinson, J. (2010). Immunologic rheumatic disorders. Journal of Allergy and Clinical Immunology, 125(2), S204-S215. doi:10.1016/j.jaci.2009.10.067.
[11]Averbuch-Heller, L., Steiner, I., & Abramsky, O. (1992). Neurologic manifestations of progressive systemic sclerosis. Archives of Neurology, 49(12), 1292–1295. doi:10.1001/archneur.1992.00530360094024
[12]Berth‐Jones, J., Coates, P. A. A., Graham‐Brown, R. A. C., & Burns, D. A. (1990). Neurological complications of systemic sclerosis‐a report of three cases and review of the literature. Clinical and Experimental Dermatology, 15(2), 91–94. doi:10.1111/j.1365–2230.1990.tb02039.
[13] Brown Jeffrey, J., & Murphy, M. J. (1985). Transverse myelopathy in progressive systemic sclerosis. Annals of Neurology, 17(6), 615–617. doi:10.1002/ana.410170617.
[14] Torabi, A.M., Patel, R. K., Wolfe, G. I., Hughes, C. S., Mendelsohn, D. B., & Trivedi, J. R. (2004). Transverse myelitis in systemic sclerosis. Archives of Neurology, 61(1), 126–128. doi:10.1001/archneur.61.1.126.
[15]Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M. I.,... Chitnis, T. (2015). Demographic and clinical features of neuromyelitis optica: A review. Multiple Sclerosis Journal, 21(7), 845–853. doi:10.1177/1352458515572406.
[16]Mok, c., Hung To, C., Mak, A., & Lun Poon, W. (2008). Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica (Vol. 35).
[17]Freitas, E., & Guimarães, J. (2015). Neuromyelitis optica spectrum disorders associated with other autoimmune diseases. Rheumatology International, 35(2), 243–253. doi:10.1007/s00296–014–3066–3